4889 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Renascience, Inc. engages in the development and sale of pharmaceuticals. It deals with the research and development of new medical solutions utilizing various modalities such as pharmaceuticals, medical devices, and artificial intelligence to solve problems in the medical field. The company was founded on February 15, 2000 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
4889 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company